James Xue,Founder and CEO of CANbridge,to Present at 2016 East West CEO Conference
Dec 17, 2015
CANbridge Appoints Mark A. Goldberg as Acting Chief Medical Officer Raises Additonal Capital in Series a Plus Round
Oct 22, 2015
CANbridge Acquires License for Apogenix’s APG101 Onco-immunotherapy in Glioblastoma for China
Jul 16, 2015
CANbridge Life Sciences, Inc. Joins the Medtech Group
Apr 08, 2015
CANbridge Life Sciences Ceo,James Xue, Presenting at Cancer Advanced Boston and Boston CEO
Apr 02, 2015